Abstract N-acylethanolamines (NAEs) are a group of lipid mediators synthesised in response to a number of physiological and pathological stimuli. Because of the low tissue concentrations of NAEs, analyses often include liquid extraction followed by solid-phase extraction and subsequent quantitation by LC/MS or GC/MS. Reported levels of NAEs vary considerably, however, and often no explanation is given to these discrepancies. Brought on by difficulties encountered during method development, the effects of using four different brands of silica-containing SPE-columns and five different brands of chloroform for sample preparation was investigated. Considerable variation in the retention and recoveries of seven NAEs and 2-arachidonoylglycerol existed between the SPE-columns. Furthermore, it was found that some chloroforms contained quantifiable amounts of N-palmitoylethanolamine (PEA) and N-stearoylethanolamine (SEA).
Introduction N-acylethanolamines (NAEs) are a group of lipid mediators synthesised in the organism in response to a variety of physiological and pathological stimuli, e.g. food intake, obesity, inflammation and cell injury. Narachidonoyl ethanolamine (AEA, anandamide) and N-oleoylethanolamine (OEA) are among the most intensively investigated NAEs, particularly in relation to obesity and appetite regulation (1) (2) (3) . In addition, Npalmitoylethanolamine (PEA) and N-stearoylethanolamine (SEA) have attracted attention in relation to antiinflammatory and apoptotic properties (4) (5) (6) .
NAEs are present in biological tissues in concentrations in the pmol/gram scale (7) (8) (9) . The ability to measure such low concentrations imposes high demands with regard to recovery of the analytes following sample preparation and the sensitivity of the analytical method used for measuring. Mass spectrometry (MS) coupled to gas chromatography (GC) (10-14) or high performance liquid chromatography (HPLC) (15) (16) (17) (18) (19) separation techniques are the current standard technologies used in NAE research, often incorporating deuterium labelled analogues as internal standards (ISTD). The choice of technique is mostly dependent on instrumentation available, as the techniques are almost equal in performance. The major difference is that GC/MS requires derivatisation to make the NAEs sufficiently volatile for analysis, making the GC/MS technique more laborious. The standard sample preparation procedures are modifications of Folchs method (20) which consists of a homogenisation and lipid extraction step using organic solvents to isolate the NAEs from the biological sample of interest, most often followed by a sample purification or concentration step using solid phase extraction (SPE) columns packed with silica or C18 material (16, 17, 21) .
A review of reports from the last decade on quantification of NAEs in various biological samples reveals large discrepancies among the published tissue concentrations found under comparable conditions. In most cases, no plausible explanation for the observed differences is given. In case an explanation is stated, it often refers to differences in the in vivo/in vitro methodologies (e.g. procedure for tissue collection or dissection) or in the analytical procedure (e.g. extraction procedure, chromatographic principles, use of ISTD or derivatisation procedures). During our studies of the effect of dietary fatty acids on tissue levels of different NAEs (7, 22, 23) we observed some artefacts during the assay development, using solid-phase extraction and mass spectrometry with internal standards. Occasionally, the OEA standard disappeared and sometimes unrealistic levels of PEA and SEA were obtained. This led to investigations of the cause of these spurious effects.
Thus far, little attention has been given to the quality of the solvents used for the sample preparation procedures as a potential interference factor, which may explain our experiences during method development and also some of the observed differences among published NAE tissue-levels. Also, although LEA, EPEA and DHEA were synthesized as described previously (24) . In brief, a fatty acid chloride intermediate was synthesized by reacting the individual fatty acid with oxalylchloride and N,Ndimethylformamide in a molar ratio of 2 to 1, respectively. The final NAE product was then synthesized by letting the respective fatty acid chlorides react with 10 molar equivalents of ethanolamine. Purity of all NAEs was verified by thin-layer chromatography using chloroform:methanol:ammonium hydroxide (80:20:2) as eluent (purities were found to be >95% by TLC with iodine-staining). Authenticities of the compounds were verified by high performance liquid chromatography coupled to mass spectrometry (LC-MS).
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Experimental
Validation of Commercial Solid Phase Extraction Columns
Four commercial silica SPE columns (Strata Si-1 Silica from Phenomenex (SupWare, Birkerød, Denmark); Supelco DSC-Si (Sigma-Aldrich, Brøndby, Denmark); Waters Sep-Pak Silica (Waters, Hedehusene, Denmark); Isolute Silica (IST, Microlab-Aarhus, Højbjerg, Denmark)) were tested for recoveries of 2-AG and NAEs. The SPE-catridges contained between 100-300 mg sorbent (1 cc to 3 cc). A solution of 500 pmol/mL of PEA, SEA, OEA, LEA, AEA, EPEA, DHEA and 2-AG in chloroform was made. 1.0 mL of this solution was applied to each of the SPE columns to be tested (n=5 for each brand of SPE column) and washed with 3 x 1.0 mL of chloroform (Wash-fraction = 4 mL). The compounds were eluted from the SPE column using increasing concentrations of MeOH in chloroform. First elution was by 4 x 1.0 mL of 3 % MeOH (E 3 % fraction), followed by 4 x 1.0 mL of 25 % MeOH (E 25 % fraction) and finally by 4 x 1.0 mL 100 % MeOH (E 100 % fraction). All fractions were evaporated to dryness under N 2 , reconstituted in 100 L chloroform, before being transferred to injection vials and analyzed by LC-MS. Three individual 1.0 mL aliquots of the NAE-solution were evaporated to dryness under N 2 , reconstituted in 100 µL chloroform and used as references for recovery calculations. Samples were analyzed by LC-MS using an Agilent 1100 series LC-MSD single quadrupole mass spectrometer (Agilent Technologies Inc, Santa Clara, CA, USA) equipped with a Phenomenex HyperClone ODS(C18) (3 m, 120Å pore size, 150 x 2.00 mm i. Identification of SEA and PEA in solvents used for sample preparation.
Sample preparation: 15, 30 and 60 mL of chloroform, ethyl acetate or hexane were evaporated to dryness under N 2 , reconstituted in 100 L MeOH and analyzed by LC-MS in SIM mode. All solvents were obtained from sealed new bottles. All glassware, used for the evaporation step, was washed twice with the respective solvent before addition of the amount of solvent to be evaporated. Washing solvents were discarded. All evaporation experiments were performed in duplicate. HCOOH. The column was kept at 40 °C and the UV-detector was set to measure at 220 nm, 230 nm, 260 nm and 280 nm. Time windows for collection of fractions from the preparative column was based on previous knowledge of using the same system for LC-MS analysis, to determine which fractions contained compounds of interest (i.e. 9,10-dichloro-SEA).
LC-MS and LC-MS/MS
Synthesis of 9,10-dichloro-SEA:
The identified reaction product from OEA in Merck LiChroSolv chloroform was synthesised by an alternate route by dissolving 12.8 mg OEA in 4 mL dichloromethane. To this solution, chlorine gas was lead from a round bottomed flask containing Mn(IV)O 2 , into which was added concentrated hydrochloric acid. The produced chlorine gas was led through a glass tube into a washing bottle containing water, in order to trap fine particulate manganese compounds and hydrochloric acid produced, and from there into the reaction vessel containing the OEA-solution and reduced iron powder. The reaction vessel was kept in an ice-bath (0 °C). Samples were taken from the reaction vessel at 0 min (before addition of chlorine gas), 15 min, and 60 min, before being diluted 400 times with MeCN and subjected to LC-MS analysis for the expected reaction product (9,10-dichloro-SEA) and remaining OEA. 
LC-MS and LC-MS/MS
Results
Validation of Commercial Solid Phase Extraction Columns
Four commercially available SPE-columns with silica sorbents were investigated with respect to recoveries of 2-AG and 7 different NAEs at clinically relevant concentrations ( fig. 2) . The results showed significant differences in retention and recoveries between SPE-columns, despite the fact that the columns were filled with the same type of sorbent (i.e silica). For most of the compounds, the columns showed average recoveries of 95-120 %. However, the recoveries were lower than 100 % for EPEA and DHEA on the Phenomenex columns (58 % and 83 %, respectively), and generally for OEA on all columns (81 -93 %).
When looking at overall retention during the wash procedure, the Phenomenex columns showed the best performance for all the studied compounds, whereas the poorest performance was with the Isolute columns that lost between 14 % (PEA) and 93 % (2-AG) during the wash procedure. For AEA, EPEA, and DHEA the losses during the wash step were considerable on the Supelco, Waters, and Isolute columns (average losses: 34 % for AEA; 33 % or EPEA; 41 % for DHEA). None of the columns were able to satisfyingly retain 2-AG, as most of the compound was lost in the wash step on all columns (losses: 39 % on Phenomenex; 71 % on Waters; 86 % on Supelco; 93 % on Isolute).The results for 2-AG notwithstanding, the average results for the investigated compounds on the respective SPE-columns were (wash loss % ± SD; total recovery % ± SD): Supelco (11.7 % ± 11.4 %; 110.3 % ± 17.1 %), Waters (18.9 % ± 10.2 %; 95.9 % ± 8.4 %), Isolute (35.3 % ± 19.4 %; 108.4 % ± 9.5 %), Phenomenex (2.2 % ± 1.6 %; 86.5 % ± 14.8 %).
Most interesting were the results showing the abilities, or lack thereof, of the individual columns to retain the poly-unsaturated compounds, which are normally present in low concentrations in biological tissues (e.g. brain (7, 8) ), i.e. AEA, EPEA, DHEA, and LEA. For these compounds, the Isolute SPE-columns lost on average 55 % already during the wash step (range 21-62 %) whereas the average losses on the other columns, for these compounds during the wash step, were 24 % (Supelco; range 3-29 %), 27 % (Waters; range 12-33 %), and 4 % (Phenomenex; range 1-4 %).
Identification of SEA and PEA in solvents used for sample preparation.
Based on previous, unpublished experiments, where PEA and SEA were found in allegedly blank samples, it was investigated whether PEA and SEA could be found in blank CHCl 3 , ethyl acetate or hexane used for sample preparation. After evaporation of increasing volumes (15, 30 and 60 mL) of the solvents and subsequent reconstitution in 100 µL MeOH (Merck LiChrosolv), the samples were analysed for the presence of PEA or SEA by LC-MS in SIM-mode. The analyses showed no presence of either PEA or SEA in ethyl acetate or hexane. In several of the chloroforms, however, substantial amounts of both PEA and SEA were found, based on the retention times and MS-data of the chromatographic peaks, which were identical to those of the authentic standards of PEA and SEA. Interestingly, PEA and SEA were identified simultaneously in a number of chloroform brands while they were both absent in the remaining chloroform brands, i.e. complete co-occurrence. The highest levels of both PEA and SEA were found in batch A of the chloroform from Fluka stabilised with amylene, while minor amounts were detected in batch A and C of the where PEA and SEA could be measured, and in some batches the two compounds were not detected. Trace amounts could be detected in Merck EMSURE chloroform stabilised with EtOH. Neither PEA nor SEA could be detected at significant levels in the remaining chloroforms. Calculating from injections of a 1 µM standard of PEA and SEA in MeCN, the concentrations of the two NAEs in the chloroform samples were estimated to be in the high pM range to low nM range (highest: 9.9 (±1.7) nM PEA and 9.1 (± 2.1) nM SEA (Fluka w.
Amylene, batch A); lowest: 90 (±24) pM PEA and 110 pM (±16) SEA (Merck EMSURE with EtOH, batch A)).
(Please refer to Supplementary Data, table S1A and S1B for calculated concentrations in the individual solvents). Identification of reaction product between OEA and Merck LiChroSolv
As data from incubations with OEA in Merck LiChroSolv stabilised with amylene showed almost complete disappearance of OEA from the solution, with the apparent major reaction product being identified as having an m/z of 396, it was decided to elucidate the identity of this reaction product.
To this end, analyses of the isotope patterns of OEA and of the reaction product were performed ( fig. 5A+B ).
The isotope pattern of OEA was as expected for a compound with an empirical formula of C 20 5B ). The only major difference was the larger relative abundance of M+3 in the experimental spectrum compared to the simulated spectrum (33 % versus 15 %, respectively).
To further verify the identity of the reaction product, 9,10-dichloro-SEA was synthesised by chlorination of the During the method development, a marked difference in recovery of NAEs and 2-AG was observed when changing the brand of silica SPE column. Therefore, a study to compare the recoveries of 2-AG and 7 NAEs from commercially available SPE columns, packed with silica stationary phases, was performed. Silica was chosen as packing material, since the initial step in most sample preparations includes solvent extraction of NAE's from tissue using a non-polar solvent. This means that using a silica packing material will allow for direct application of the tissue solvent extract to be applied to the column without the need for evaporation and re-dissolving in aqueous solvent (with the solubility problems that may entail), as will be required if using a C18 packing material. It was found that while recoveries from the SPE columns in general were acceptable, there were significant differences between columns from the four vendors. Furthermore, the retention and recoveries were compound dependent, with significant loss of 2-AG during the wash step on all columns and with OEA having the lowest recovery on all the columns ( Fig. 2A and 2B) . A similar observation on differences in column performance was made by Hardison et al. (21), who turned towards replacement of silica with C18 packing material as a way to solve problems with poor analyte recovery. The present study describes in detail for the first time that silica-based SPE columns may still be useful provided an appropriate brand of silica is chosen. Furthermore, the addition of acids or bases, e.g. TEA or TFA, to the elution solvent was not investigated in the present study, but has previously been reported to have a marked effect on recoveries (19) .
A very important and most surprising result, arising from the development and validation of an assay for measuring endocannabinoids and NAEs in biological tissues in our laboratory, was the discovery of PEA and SEA as permanent contaminants of some commercially branded chloroform products. Proof of the presence of these compounds as actual contaminations in the chloroforms, and not just artefacts caused by e.g. carryover in the analytical system, was given by the fact that concentrating increasing volumes of solvent lead to corresponding increases in the amount of PEA and SEA found in the samples (Fig. 3A and 3B) .
Furthermore, the identities of the contaminations were confirmed based on retention times and MS/MS spectra identical to authentic standards of PEA and SEA. Initially, the presence of these contaminants in the solvents was somewhat confounding. However, a careful review of the literature revealed that NAEs are widely used in the industry as additives in cosmetics, detergent powders, detergent liquids, fabric softeners, corrosion inhibitors, textile auxiliaries and in shampoos to improve foam stabilization and viscosity (28) . The contaminations of commercially branded chloroform products could therefore originate from detergents used to clean manufacturing plant facilities or containers and bottles used to store the chloroform products. Along with this, it could be speculated that the contaminations stem from detergents used to clean glassware in the laboratory. However, due to the negative results obtained when analyzing for the contaminants in e.g.
ethylacetate or hexane, this appears not to be the main source. The findings are particularly interesting since chloroform is used in Folch's method for lipid extraction and in most sample preparation methods prior to MS-based analysis of NAEs, including PEA and SEA (13, 16, 20, (29) (30) (31) . The concentrations of PEA and SEA in chloroform are relatively small, however, and usually will not contribute significantly to the analytical signal, even when analyzing small amounts of PEA or SEA in samples dissolved directly in this solvent. The problem may arise when using large volumes of chloroform for lipid extraction and sample purification on silica SPE columns. The PEA and SEA contaminations will be concentrated on the silica SPE columns during the sample preparation and are eluted along with the endogenous amounts of PEA and SEA. This issue becomes problematic, as it leads to measurements of artificially high levels of PEA and SEA in biological samples and may be a plausible explanation for some of the discrepancies among published tissue levels of e.g. PEA and SEA; especially for very small biological samples (e.g. 50-100 mg of brain homogenates), where the contaminations of PEA and SEA in chloroform could contribute significantly to the analytical signal. A general tendency in the majority of published papers is that no information is given on the particular brand of chloroform used in the lipid extraction and sample preparation procedures. The presence of PEA and SEA in some brands of chloroform, as has been presented in this paper, gives rise to difficulties in discerning reliable data from false positive values or artificially high concentrations of these compounds.
Due to the presence of PEA and SEA in the initial chloroform brand used in our lab, which was encountered during development of a sample preparation method using silica SPE columns, a change was made to use Merck LiChrosolv chloroform instead. However, it was observed that the use of Merck LiChrosolv chloroform resulted in the disappearance of OEA from samples. Initial thoughts were centred around the reaction between the amylene used to stabilize the chloroform and the alcohol group on the ethanolamine part of OEA. This was based in part on data found in the literature, reporting on the reactivity of amylene (2-methyl-2-butene) with ethanol (32, 33) and also on the presence of a reaction product with m/z 396, i.e. a mass increase of 70 u, which corresponded to the expected mass difference from the reaction with amylene.
However, analysis of the isotope pattern of the reaction product revealed the presence of two chlorine atoms, which did not support the idea of the reaction with amylene ( fig. 5B ). In order to investigate whether the disappearance of OEA was a general problem for chloroforms containing amylene as stabilizer, incubations of OEA in chloroforms of different brands, stabilized with either amylene or EtOH, were performed. These showed that disappearance of OEA was not generally happening in chloroforms containing amylene or EtOH, but was constrained to a single brand ( Fig. 4A and 4B ). This further substantiated that amylene was not responsible for the disappearance of OEA.
The mass increase relative to OEA of 70 u in the reaction product corresponded well with the addition of two chlorine atoms to OEA, with the most likely explanation being an addition of chlorine radicals to the unsaturated -9 double-bond of OEA, resulting in the possible reaction-product 9,10-dichloro-SEA. Further evidence to this came from the isotope pattern of the reaction product, which also corresponded to the presence of two chlorine atoms in the molecule. In order to support this notion, synthesis of 9,10-dichloro-SEA from OEA was performed by leading chlorine gas through a solution of OEA in dichloromethane in the presence of reduced ion as a catalyst, which is a classic method for chlorination of alkenes. This resulted in a product with similar retention time and m/z-value to the observed reaction product OEA in Merck of the other fragments were seen to contain chlorine, indicating that the two chlorine atoms are very labile during CID (fig. 6B) . Further information about the position of the chlorine atoms was difficult to extract from the MS/MS spectra of the reaction product, even through comparison with the MS/MS spectra for OEA.
Structural information about fatty acids is notoriously difficult to obtain using soft ionization techniques (ESI) with low energy CID as a number of mechanisms give rise to both charge-remote fragmentation, hydrogenshifts and possibly charge-mediated fragmentations (34) (35) (36) . However, some evidence for the saturation of the double-bond in the reaction product could be inferred from the fact that in the spectra for OEA few fragment ions were seen past the vinylic C 10-11 bond, whereas for the reaction product with m/z 396 more fragments were seen up to C 12-13 (34) .
In order to further elucidate the structure of the reaction product, The source of the chlorine that reacted with OEA may be the chloroform itself which, upon reaction with UVlight and oxygen and/or with metal ions, readily produces free chlorine, phosgene and hydrochloric acid (37) (38) (39) . Alternatively, chlorine may stem from the manufacturing of chloroform by chlorination of methane, or from produced carbon tetrachloride left over from the manufacturing process, which has not been adequately removed. Chlorine, either as Cl 2 , HCl or as radicals from chloroform or carbon tetrachloride, may react with the unsaturated bond in OEA and possibly also with non-vinylic carbons to yield the corresponding chlorinated products of OEA. The latter were not identified in this study, as attention was focused on the major reaction product observed, i.e. 9,10-dichloro-SEA. As mentioned previously, however, a number of minor reaction products were also observed by mass spectrometry of the mixture of OEA with Merck LiChrosolv chloroform, and it cannot be ruled out that other chlorinated reaction products on non-vinylic carbons could be found among these. Consequently, it should be realised that reactions with chlorine may occur to all unsaturated NAEs, e.g anandamide and 2-arachidinoylglycerol -two endocannabinoids often measured in mammalian tissues (40, 41) -as well as possibly saturated NAEs, provided a susceptible brand of chloroform is used.
The described results emphasize the need for thorough method validation in bioanalysis with regards to analyte recovery during sample preparation, and the potential presence of interfering compounds from the matrix or solvents used (i.e. PEA and SEA in chloroform). Furthermore, some thought should be given the quality of the solvents used. Specifically, initial and subsequent periodical checks should be performed for the presence of phosgene and chlorine in chloroform, as these may react with unsaturated NAEs, as was demonstrated in this study.
In all circumstances, method revalidation should be performed if changes are made to the brand of SPEcolumn or brand of solvent, and if possible QC samples should be included in the analyses in order to catch problems at an early point and to improve quantitation. www.jlr.org
